Anthem Biosciences IPO: NIIs Lead Bidding On Final Day, GMP Declines
The Anthem Biosciences IPO was subscribed 7.79 times as of 11:40 a.m. on Wednesday.
The initial public offering of Anthem Biosciences Ltd. has been subscribed to nearly eight times the offer on its third and final day on Friday. Non-institutional investors have placed the most bids, followed by large institutions. The IPO was fully subscribed on day two.
The price band for the IPO is Rs 540 to Rs 570 per share of a face value of Rs 2 each. The IPO is a book-building issue of Rs 3,395 crore. The issue is entirely an offer for sale of 5.96 crore shares, from its promoters, investors and other selling shareholders.
Since this IPO is fully an OFS, the contract research, development and manufacturing company will not receive any funds, which will be directed to the selling shareholders.
IPO Details
Issue opens: July 14.
Issue closes: July 16.
Issue price band: Rs 540 and Rs 570 per share.
Lot size: 26 shares.
Total issue size: Rs 3,395 crore.
Type: Book-building issue.
Tentative listing date: July 17.
Subscription Status: Day Three
The Anthem Biosciences IPO was subscribed 7.79 times as of 11:40 a.m. on Wednesday.
Qualified institutional buyers: 4.81 times.
Non-institutional buyers: 22.2 times.
Retail investors: 3.34 times
Portion reserved for employees: 3.75 times.
Anthem Biosciences IPO GMP
The grey market premium for Anthem Biosciences IPO rose from Rs 156 on Tuesday to Rs 150, as of 10:30 a.m., according to InvestorGain. That implies listing at a premium of 26.3% at an estimated price of Rs 720.
GMP or grey market price is not an official indicator and is based on market speculation.
Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisers and read red herring prospectus thoroughly before placing bids.
